These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 6287380)

  • 1. [Leukocyte migration inhibition elicited by Epstein-Barr virus antigen. Reaction potential in infectious mononucleosis as well as in states of immune deficiency and immunosuppression].
    Szigeti R; Klein E; Masucci MG; Ernberg I; Masucci G; Svedmyr E; Klein G
    Orv Hetil; 1982 May; 123(20):1217-21. PubMed ID: 6287380
    [No Abstract]   [Full Text] [Related]  

  • 2. [Specific delayed hypersensitivity to Epstein-Barr virus: in vitro study by leukocyte migration inhibition].
    Szigeti R; Timár L; Knoll J; Kuti D; Révész T
    Orv Hetil; 1980 May; 121(19):1121-4. PubMed ID: 6251414
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunopathology of infectious mononucleosis and other complications of Epstein-Barr virus infections.
    Purtilo DT
    Pathol Annu; 1980; 15(Pt 1):253-99. PubMed ID: 6255399
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of different Epstein-Barr virus-determined antigens (EBNA, EA, and VCA) on the leukocyte migration of healthy donors and patients with infectious mononucleosis and certain immunodeficiencies.
    Szigeti R; Masucci MG; Henle W; Henle G; Purtilo D; Klein G
    Clin Immunol Immunopathol; 1982 Jan; 22(1):128-38. PubMed ID: 6288294
    [No Abstract]   [Full Text] [Related]  

  • 5. Epstein-Barr virus-specific serology in immunologically compromised individuals.
    Henle W; Henle G
    Cancer Res; 1981 Nov; 41(11 Pt 1):4222-5. PubMed ID: 6272966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibody formation against specific Epstein-Barr virus antigens in infectious mononucleosis with tonsillectomy in the acute phase of the disease].
    Sauerbrei A; Sprössig M; Wutzler P; Färber I; Schweizer H; Swoboda R; Wilke J
    Laryngol Rhinol Otol (Stuttg); 1983 Apr; 62(4):170-4. PubMed ID: 6191167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Infectious mononucleosis].
    Wilmes E
    MMW Munch Med Wochenschr; 1982 Nov; 124(45):995-7. PubMed ID: 6294511
    [No Abstract]   [Full Text] [Related]  

  • 8. Summary: symposium on Epstein-Barr virus-induced lymphoproliferative diseases in immunodeficient patients.
    Klein G; Purtilo D
    Cancer Res; 1981 Nov; 41(11 Pt 1):4302-4. PubMed ID: 6272974
    [No Abstract]   [Full Text] [Related]  

  • 9. [Analysis of viral capsid anti-antigen antibodies of the Epstein Barr virus in infectious mononucleosis. Comparative evaluation of a fluorescence method with classic methods].
    Picerno G; Lari M; Fregoso F; Musmanno G
    Quad Sclavo Diagn; 1983 Dec; 19(4):489-98. PubMed ID: 6330785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-mediated immunity to Epstein-Barr virus and a blocking factor in patients with infectious mononucleosis.
    Lai PK; Mackay-Scollay EM; Fimmel PJ; Alpers MP; Keast D
    Nature; 1974 Dec; 252(5484):608-10. PubMed ID: 4372559
    [No Abstract]   [Full Text] [Related]  

  • 11. Leukocyte migration inhibition detects cross-reacting antigens between cells transformed by Epstein-Barr virus (EBV) and EBV-like simian viruses.
    Szigeti R; Rabin H; Timar L; Klein G
    Intervirology; 1986; 26(3):121-8. PubMed ID: 3034820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Demonstration of Epstein-Barr virus capsid antigen (VCA) in lymphocyte cultures from patients with mononucleosis].
    Szucs G; Ternák G
    Orv Hetil; 1977 Aug; 118(32):1891-2. PubMed ID: 196242
    [No Abstract]   [Full Text] [Related]  

  • 13. Leukocyte migration inhibition with Epstein-Barr virus negative and positive cell extracts.
    Szigeti R; Timár L; Révész T
    Allergy; 1980 Mar; 35(2):97-103. PubMed ID: 6155797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell mediated immunity during infectious mononucleosis to Epstein-Barr virus associated antigens.
    Periman P; Levine PH; Ablashi DV; Royston I
    Int J Cancer; 1977 Oct; 20(4):506-11. PubMed ID: 199544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of the antibodies to Epstein-Barr virus capsid antigen in the diagnosis of infectious mononucleosis in children].
    Krotochwil-Skrzypkowa M; Najberg G
    Pediatr Pol; 1982; 57(9):633-43. PubMed ID: 6302631
    [No Abstract]   [Full Text] [Related]  

  • 16. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
    Wasik M; Myc A; Matej H; Rudzka L
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):871-8. PubMed ID: 6331340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine.
    Epstein MA; Morgan AJ
    Clin Exp Immunol; 1983 Aug; 53(2):257-71. PubMed ID: 6309441
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term T-cell-mediated immunity to Epstein-Barr virus.
    Rickinson AB; Moss DJ; Wallace LE; Rowe M; Misko IS; Epstein MA; Pope JH
    Cancer Res; 1981 Nov; 41(11 Pt 1):4216-21. PubMed ID: 6272965
    [No Abstract]   [Full Text] [Related]  

  • 19. [The expression of periphery blood leucocyte CCR3 and CCR5 in the children with Epstein-Barr virus associated infectious mononucleosis].
    Qi TX; Gao GH; Liu SH
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Oct; 24(5):355-7. PubMed ID: 21280323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibodies against non-structural antigens of Epstein-Barr virus in children with infectious mononucleosis].
    Najberg G
    Med Dosw Mikrobiol; 1983; 35(1):55-9. PubMed ID: 6314071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.